Cogent Biosciences Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

5.88

0.25 (4.44%)

At close: May 02, 2025, 3:59 PM

5.97

1.57%

After-hours: May 02, 2025, 04:52 PM EDT

Cogent Biosciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	n/a	n/a	n/a	n/a	7.87M	22.5M	9.73M	8.36M	6.36M
Cost of Revenue	n/a	3.59M	5.88M	147K	25.74K	43.71K	n/a	n/a	n/a
Gross Profit	n/a	-3.59M	-5.88M	-147K	7.85M	22.46M	9.73M	8.36M	6.36M
Operating Income	-275.94M	-208.13M	-147.84M	-75.55M	-82.2M	-32.18M	-36.01M	-26.15M	-19.07M
Interest Income	18.09M	13.08M	3.99M	467K	144K	267K	1.15M	386K	265K
Pretax Income	-255.86M	-192.41M	-140.24M	-72.27M	-74.81M	-31.83M	-34.53M	-25.49M	-18.12M
Net Income	-255.86M	-192.41M	-132.64M	-71.81M	-66.45M	-30.27M	-34.53M	-25.49M	-18.12M
Selling & General & Admin	43.28M	34.38M	26.21M	19.64M	17.42M	10.97M	7.45M	4.68M	3.43M
Research & Development	232.66M	170.17M	121.63M	55.91M	72.65M	43.71M	38.28M	29.83M	21.99M
Other Expenses	n/a	n/a	3.61M	2.81M	-246K	78K	320K	274K	681K
Operating Expenses	275.94M	208.13M	147.84M	75.55M	90.07M	54.68M	45.74M	34.51M	25.43M
Interest Expense	n/a	n/a	3.99M	n/a	n/a	n/a	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	275.94M	208.13M	147.84M	75.55M	90.07M	54.68M	45.74M	34.51M	25.43M
Income Tax Expense	n/a	n/a	-7.6M	-467K	-8.36M	-1.56M	1.47M	-386K	-265K
Shares Outstanding (Basic)	103.86M	79.66M	58.74M	38.73M	11.08M	7.62M	6.22M	7.4M	5.86M
Shares Outstanding (Diluted)	103.86M	79.66M	58.74M	38.73M	11.08M	7.62M	6.22M	7.4M	7.4M
EPS (Basic)	-3.49	-2.42	-2.26	-1.85	-6	-3.97	-5.55	-3.45	-3.1
EPS (Diluted)	-3.49	-2.42	-2.26	-1.85	-6	-3.97	-5.55	-3.45	-2.45
EBITDA	-275.94M	-205.86M	-134.36M	-75.4M	-34.57M	-30.89M	-34.68M	-24.98M	-18.24M
EBIT	-275.94M	-208.13M	-147.84M	-75.55M	-74.81M	-32.18M	-36.01M	-26.15M	-19.07M
Depreciation & Amortization	n/a	2.27M	5.88M	147K	720K	1.29M	1.32M	1.17M	830K